相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pancreatic Neuropathy Results in Neural Remodeling and Altered Pancreatic Innervation in Chronic Pancreatitis and Pancreatic Cancer
Gueralp Onur Ceyhan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells
Ido Nevo et al.
CANCER LETTERS (2009)
Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis
Julio E. Valdivia-Silva et al.
CANCER LETTERS (2009)
Membrane Microvesicles as Actors in the Establishment of a Favorable Prostatic Tumoral Niche: A Role for Activated Fibroblasts and CX3CL1-CX3CR1 Axis
Donatello Castellana et al.
CANCER RESEARCH (2009)
Pancreatic Neuropathy and Neuropathic Pain-A Comprehensive Pathomorphological Study of 546 Cases
Gueralp O. Ceyhan et al.
GASTROENTEROLOGY (2009)
An engineered CX3CR1 antagonist endowed with anti-inflammatory activity
Karim Dorgham et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
The Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S
Anna K. Clark et al.
JOURNAL OF NEUROSCIENCE (2009)
Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis
Gueralp O. Ceyhan et al.
LABORATORY INVESTIGATION (2009)
Expression of Fractalkine (CX3CL1) and Its Receptor in Endotoxin-Induced Uveitis
Liqun Chu et al.
OPHTHALMIC RESEARCH (2009)
Pancreatic pain
Guralp O. Ceyhan et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2008)
CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: Potential role in prostate cancer bone tropism
Whitney L. Jamieson et al.
CANCER RESEARCH (2008)
The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
Federica Marchesi et al.
CANCER RESEARCH (2008)
Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia
Jewon Ryu et al.
CARDIOVASCULAR RESEARCH (2008)
Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2(-/-) mice - Evidence for independent chemokine functions in atherogenesis
Noah Saederup et al.
CIRCULATION (2008)
Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy
David L. Blum et al.
CLINICAL CANCER RESEARCH (2008)
The fractalkine receptor CX3CR1 is involved in due to chronic hepatitis C infection
Hermann E. Wasmuth et al.
JOURNAL OF HEPATOLOGY (2008)
Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis
Yuko Ishida et al.
JOURNAL OF IMMUNOLOGY (2008)
Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour
Fiona E. Holmes et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors
B. A. Nassar et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans
Mikihiko Yasuda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the jak-stat5 pathway
Xiao Ping Yang et al.
CIRCULATION RESEARCH (2007)
Neuronal chemokines: Versatile messengers in central nervous system cell interaction
A. H. de Haas et al.
MOLECULAR NEUROBIOLOGY (2007)
CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration
Christophe Combadiere et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma
L. Tang et al.
GENE THERAPY (2007)
Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine
Zhi-Ye Zhuang et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve
Ping Hu et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
Anna K. Clark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats
Xiaohong Chen et al.
BRAIN RESEARCH (2007)
New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis
Sun Shan et al.
PAIN (2007)
The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis
Gueralp O. Ceyhan et al.
GUT (2007)
Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma
Takeshi Matsubara et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer
S. Vitale et al.
GUT (2007)
Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells
Yan Zeng et al.
CANCER RESEARCH (2007)
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: Impact of pre-inflammatory stimuli and renin-angiotensin system modulators
Stavros Apostolakis et al.
THROMBOSIS RESEARCH (2007)
Expression and targeting of CX(3)CL1 (Fractalkine) in renal tubular epithelial cells
Anne M. Durkan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Leukocyte influx in atherosclerosis
Elena Galkina et al.
CURRENT DRUG TARGETS (2007)
Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury
Kengo Furuichi et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Control of microglial neurotoxicity by the fractalkine receptor
Astrid E. Cardona et al.
NATURE NEUROSCIENCE (2006)
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer
F. Andre et al.
ANNALS OF ONCOLOGY (2006)
Dendritic cells modified to express fractalkine/CX3CLI in the treatment of preexisting tumors
M Nukiwa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype
S Brand et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine
E Milligan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy
JK Damås et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2
Y Zeng et al.
CANCER LETTERS (2005)
Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain
JA Lindia et al.
JOURNAL OF PAIN (2005)
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
H Xin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice
A Inoue et al.
ARTHRITIS AND RHEUMATISM (2005)
Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules
A Ludwig et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance
JH Niess et al.
SCIENCE (2005)
Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective
LR Bisset et al.
CURRENT OPINION IN PULMONARY MEDICINE (2005)
Dual role of CCR2 during initiation and progression of collagen-induced arthritis:: Evidence for regulatory activity of CCR2+ T cells
H Brühl et al.
JOURNAL OF IMMUNOLOGY (2004)
Fractakine (CX3CL1) and fractakine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions
GM Verge et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine
IN Johnston et al.
JOURNAL OF NEUROSCIENCE (2004)
CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells
SA Shulby et al.
CANCER RESEARCH (2004)
Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1
CN Davis et al.
MOLECULAR PHARMACOLOGY (2004)
Fractalkine reduces N-methyl-D-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation
K Deiva et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats
ED Milligan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
AD Lucas et al.
CIRCULATION (2003)
Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1
J Guo et al.
IMMUNOLOGY LETTERS (2003)
The chemokine CX3CL1 regulates NK cell activity in vivo
LA Robinson et al.
CELLULAR IMMUNOLOGY (2003)
Rats and mice exhibit distinct inflammatory reactions after spinal cord injury
JM Sroga et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration
HJ Anders et al.
JOURNAL OF IMMUNOLOGY (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells
J Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The CX3C chemokine fractalkine in allergic asthma and rhinitis
AC Rimaniol et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Expression of the fractalkine receptor (CX3CR1) in human kidney diseases
S Segerer et al.
KIDNEY INTERNATIONAL (2002)
Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression
M Nishimura et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS
PM Hughes et al.
GLIA (2002)
Tumor necrosis factor-α-converting enzyme mediates the inducible cleavage of fractalkine
CL Tsou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
JA Belperio et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis
W Peters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mutational analysis of the fractalkine chemokine domain - Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion
JK Harrison et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Generation and analysis of mice lacking the chemokine fractalkine
DN Cook et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
S Jung et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1
S Faure et al.
SCIENCE (2000)
Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation
AM Fong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor
M Liang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice
JE Bird et al.
KIDNEY INTERNATIONAL (2000)
分享论文
